Chen Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chen Liu has a total of 326 co-authors. Here are the top co-authors by number of shared publications:
- Xuchen Zhang
Yale School of Medicine
15 shared publications - Ann W. Hsing
Stanford Cancer Center, Stanford University, Palo Alto, CA, US
14 shared publications - Bubu Banini
Section of Digestive Diseases, Yale School of Medicine, New Haven, CT 06510, USA
14 shared publications - Catherine Mezzacappa
VA Connecticut Healthcare System , West Haven, Connecticut
14 shared publications - Chul S. Hyun
Section of Digestive Diseases, Yale School of Medicine, New Haven, USA
14 shared publications - Jung Eun Lee
Department of Food and Nutrition, College of Human Ecology, Seoul National University, Seoul, Korea
14 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents sensitivity analyses of H. pylori seropositivity and incident metabolic dysfunction–associated steatotic liver disease using alternative seropositivity thresholds.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents sensitivity analyses of H. pylori seropositivity and incident metabolic dysfunction–associated steatotic liver disease using alternative seropositivity thresholds.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S9 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents sparse-data and model-robustness analyses using Firth-penalized Cox and modified Poisson models.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S9 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents sparse-data and model-robustness analyses using Firth-penalized Cox and modified Poisson models.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents baseline characteristics of the UK Biobank multiplex serology subsample and the analytic cohorts included in the study.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents baseline characteristics of the UK Biobank multiplex serology subsample and the analytic cohorts included in the study.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents inverse probability–weighted, negative control, and competing-risk analyses of the association between H. pylori infection and incident metabolic dysfunction–associated steatotic liver disease.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents inverse probability–weighted, negative control, and competing-risk analyses of the association between H. pylori infection and incident metabolic dysfunction–associated steatotic liver disease.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This figure shows participant selection for the UK Biobank analysis of H. pylori infection and incident metabolic dysfunction–associated steatotic liver disease.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This figure shows participant selection for the UK Biobank analysis of H. pylori infection and incident metabolic dysfunction–associated steatotic liver disease.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents lagged and landmark analyses evaluating the robustness of the association between H. pylori infection and incident metabolic dysfunction–associated steatotic liver disease.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents lagged and landmark analyses evaluating the robustness of the association between H. pylori infection and incident metabolic dysfunction–associated steatotic liver disease.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table provides the complete search strategy used to identify studies for the systematic review and meta-analysis.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table provides the complete search strategy used to identify studies for the systematic review and meta-analysis.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents baseline characteristics of the UK Biobank study population by CagA and H. pylori serostatus.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents baseline characteristics of the UK Biobank study population by CagA and H. pylori serostatus.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S10 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table summarizes characteristics of prospective studies included in the meta-analysis of H. pylori infection and metabolic dysfunction–associated steatotic liver disease.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S10 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table summarizes characteristics of prospective studies included in the meta-analysis of H. pylori infection and metabolic dysfunction–associated steatotic liver disease.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents associations between antigen-specific H. pylori seropositivity and incident metabolic dysfunction–associated steatotic liver disease in the UK Biobank.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
This table presents associations between antigen-specific H. pylori seropositivity and incident metabolic dysfunction–associated steatotic liver disease in the UK Biobank.